Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ECL | Common Stock | Options Exercise | $83.2K | +1.3K | +6.13% | $64.00 | 22.5K | Sep 8, 2021 | Direct | |
transaction | ECL | Common Stock | Options Exercise | $270K | +3.2K | +14.21% | $84.27 | 25.7K | Sep 8, 2021 | Direct | |
transaction | ECL | Common Stock | Sale | -$1.03M | -4.5K | -17.5% | $229.00 | 21.2K | Sep 8, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ECL | Non-Employee Director Stock Option (Right to Buy) | Options Exercise | $0 | -1.3K | -100% | $0.00* | 0 | Sep 8, 2021 | Common Stock | 1.3K | $64.00 | Direct | F2 |
transaction | ECL | Non-Employee Director Stock Option (Right to Buy) | Options Exercise | $0 | -3.2K | -100% | $0.00* | 0 | Sep 8, 2021 | Common Stock | 3.2K | $84.27 | Direct | F2 |
Id | Content |
---|---|
F1 | This transaction was executed in multiple trades at prices ranging from $229.000 to $229.035, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
F2 | The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the "Date Exercisable" column represents the first vesting date. |